Advancing mid‐rectal cancer surgery: Unveiling the potential of natural orifice specimen extraction surgery in comparison to conventional laparoscopic‐assisted resection
Cancer Reports · 2024-05 · 7 (5)
DOI: 10.1002/cnr2.2003 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Reports, online erschienen am 04.05.2024. Verfasst von Shan Muhammad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Laparoscopy, Rectal Neoplasms, Natural Orifice Endoscopic Surgery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Mid‐rectal cancer treatment traditionally involves conventional laparoscopic‐assisted resection (CLAR). This study aimed to assess the clinical and therapeutic advantages of Natural Orifice Specimen Extraction Surgery (NOSES) over CLAR.
Aims
To compare the clinical outcomes, intraoperative metrics, postoperative recovery, complications, and long‐term prognosis between NOSES and CLAR groups. Materials & Methods A total of 136 patients were analyzed, with 92 undergoing CLAR and 44 undergoing NOSES. Clinical outcomes were evaluated, and propensity score matching (PSM) was employed to control potential biases.
Results
The NOSES group exhibited significant improvements in postoperative recovery, including lower pain scores on days 1, 3, and 5 (p < .001), reduced need for additional analgesics (p = .02), shorter hospital stays (10.8 ± 2.3 vs. 14.2 ± 5.3 days; p < .001), and decreased intraoperative blood loss (48.1 ± 52.7 mL vs. 71.0 ± 55.0 mL; p = .03). Patients undergoing NOSES also reported enhanced satisfaction with postoperative abdominal appearance and better quality of life. Additionally, the NOSES approach resulted in fewer postoperative complications.
Conclusion
While long‐term outcomes (overall survival, disease‐free survival, and local recurrence rates) were comparable between the two methods, NOSES demonstrated superior postoperative outcomes compared to CLAR in mid‐rectal cancer treatment, while maintaining similar long‐term oncological safety. These findings suggest that NOSES could serve as an effective alternative to CLAR without compromising long‐term results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Laboratory of Translational Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Children's and Adolescent Health, Public Health College of Harbin Medical University, Harbin, China.
- Department of General Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Shan Muhammad
Förderung
- Special Project for Research and Development in Key areas of Guangdong Province
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Muhammad, S., Jiang, Z., Fan, T., Tang, Q., Hai, Y., Ehsan, S. B. E., Bilal, M., Zubayraeva, A. A., Gao, Y., & He, J. (2024). Advancing mid‐rectal cancer surgery: Unveiling the potential of natural orifice specimen extraction surgery in comparison to conventional laparoscopic‐assisted resection. Cancer Reports, 7(5). https://doi.org/10.1002/cnr2.2003
Vancouver
Muhammad S, Jiang Z, Fan T, Tang Q, Hai Y, Ehsan SBE, et al. Advancing mid‐rectal cancer surgery: Unveiling the potential of natural orifice specimen extraction surgery in comparison to conventional laparoscopic‐assisted resection. Cancer Reports. 2024;7(5). doi:10.1002/cnr2.2003
BibTeX
@article{Muhammad2024,
author = {Muhammad, Shan and Jiang, Zheng and Fan, Tao and Tang, QingChao and Hai, Yang and Ehsan, Sundas Bint E and Bilal, Maimoona and Zubayraeva, Albina A and Gao, YiBo and He, Jie},
title = {Advancing mid‐rectal cancer surgery: Unveiling the potential of natural orifice specimen extraction surgery in comparison to conventional laparoscopic‐assisted resection},
journal = {Cancer Reports},
year = {2024},
volume = {7},
number = {5},
doi = {10.1002/cnr2.2003}
}
EUVIMED